Vivo Capital, LLC Q1 2020 Filing
Filed May 15, 2020
Portfolio Value
$1.1T
Holdings
53
Report Date
Q1 2020
Filing Type
13F-HR
All Holdings (53 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ASNDAscendis Pharma A/S | 2,003,147 | $225.6B | 20.43% | |
| 2 | —New Frontier Health Corp | 14,300,000 | $118.0B | 10.69% | |
| 3 | —Kadmon Holdings Inc | 12,539,515 | $52.5B | 4.76% | |
| 4 | ARQTArcutis Biotherapeutics Inc | 1,686,527 | $50.3B | 4.55% | |
| 5 | CRNXCrinetics Pharmaceuticals Inc | 3,320,801 | $48.8B | 4.42% | |
| 6 | —Zymeworks Inc | 1,101,236 | $39.1B | 3.54% | |
| 7 | SVASinovac Biotech Ltd. | 5,900,000 | $38.2B | 3.46% | |
| 8 | —Forty Seven Inc | 395,691 | $37.8B | 3.42% | |
| 9 | PASGPassage Bio Inc | 2,229,587 | $35.1B | 3.18% | |
| 10 | AVDLAvadel Pharmaceuticals PLC | 3,575,424 | $28.4B | 2.57% | |
| 11 | ARWRArrowhead Pharmaceuticals Inc | 768,674 | $22.1B | 2.00% | |
| 12 | —Zogenix Inc | 888,724 | $22.0B | 1.99% | |
| 13 | VSTMVerastem Inc | 8,139,535 | $21.5B | 1.95% | |
| 14 | SELBUSDSelecta Biosciences Inc | 7,846,509 | $18.9B | 1.71% | |
| 15 | —Sierra Oncology, Inc | 1,917,074 | $18.8B | 1.71% | |
| 16 | AKROAkero Therapeutics Inc | 808,247 | $17.1B | 1.55% | |
| 17 | CDXSCodexis, Inc | 1,493,903 | $16.7B | 1.51% | |
| 18 | AMRSEURAmyris, Inc | 6,492,247 | $16.6B | 1.51% | |
| 19 | KRTXKaruna Therapeutics Inc | 223,692 | $16.1B | 1.46% | |
| 20 | MEIPUSDMEI Pharma Inc | 9,784,422 | $15.8B | 1.43% | |
| 21 | FIXXEURHomology Medicines, Inc. | 1,008,562 | $15.7B | 1.42% | |
| 22 | —Myokardia Inc | 333,621 | $15.6B | 1.42% | |
| 23 | —Aduro Biotech Inc | 5,118,560 | $14.0B | 1.27% | |
| 24 | ORTXUSDOrchard Therapeutics plc | 1,627,225 | $12.3B | 1.11% | |
| 25 | CLDNEUREiger BioPharmaceuticals Inc | 1,791,257 | $12.2B | 1.10% | |
| 26 | RCKTRocket Pharmaceuticals Inc | 860,648 | $12.0B | 1.09% | |
| 27 | KNSAKiniksa Pharmaceuticals | 759,050 | $11.8B | 1.06% | |
| 28 | 1T7Tricida, Inc. | 524,290 | $11.5B | 1.04% | |
| 29 | ZLABZai Lab Limited | 222,107 | $11.4B | 1.04% | |
| 30 | KALVKalVista Pharmaceuticals Inc. | 1,476,796 | $11.3B | 1.02% | |
| 31 | 1K0IGM Biosciences Inc | 199,626 | $11.2B | 1.02% | |
| 32 | —Avrobio Inc | 717,753 | $11.2B | 1.01% | |
| 33 | —Menlo Therapeutics Inc. | 3,843,824 | $10.3B | 0.93% | |
| 34 | TREURTrillium Therapeutics Inc | 2,054,468 | $8.3B | 0.75% | |
| 35 | COLLCollegium Pharmaceutical Inc | 447,173 | $7.3B | 0.66% | |
| 36 | AUPHAurinia Pharmaceuticals Inc. | 500,732 | $7.3B | 0.66% | |
| 37 | KALAKala Pharmaceuticals, Inc. | 786,883 | $6.9B | 0.63% | |
| 38 | MTNBEURMatinas Biopharma Hldgs Inc | 11,279,323 | $6.8B | 0.61% | |
| 39 | BDTXBlack Diamond Therapeutics Inc | 252,119 | $6.3B | 0.57% | |
| 40 | VRNAVerona Pharma PLC | 1,492,951 | $6.2B | 0.56% | |
| 41 | —Soleno Therapeutics, Inc. | 2,021,377 | $4.8B | 0.44% | |
| 42 | —Chiasma Inc | 1,272,156 | $4.6B | 0.42% | |
| 43 | XENEXenon Pharmaceuticals Inc | 396,589 | $4.5B | 0.41% | |
| 44 | —Constellation Pharmaceutical | 140,298 | $4.4B | 0.40% | |
| 45 | RVMDRevolution Medicines Inc | 199,518 | $4.4B | 0.40% | |
| 46 | GLMDGalmed Pharmaceuticals Ltd | 860,103 | $3.0B | 0.27% | |
| 47 | ATRCAtricure Inc | 64,573 | $2.2B | 0.20% | |
| 48 | ACRSAclaris Therapeutics, Inc. | 1,647,214 | $1.7B | 0.16% | |
| 49 | CBAYUSDCymabay Therapeutics Inc | 1,077,467 | $1.6B | 0.14% | |
| 50 | QUREUniqure NV | 22,932 | $1.1B | 0.10% | |
| 51 | —DBV Technologies S.A. | 269,995 | $1.1B | 0.10% | |
| 52 | —Nabriva Therapeutics AG | 1,704,130 | $980.0M | 0.09% | |
| 53 | DTILPrecision Biosciences Inc | 140,255 | $846.0M | 0.08% |